Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Health Catalyst, Inc. (HCAT : NSDQ)

• Company Description    Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. Number of Employees: 1,500

• Price / Volume Information    Yesterday's Closing Price: $4.06 Daily Weekly Monthly 20 Day Moving Average: 542,381 shares Shares Outstanding: 69.60 (millions) Market Capitalization: $282.58 (millions) Beta: 1.51 52 Week High: $9.24 52 Week Low: $3.49 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.98% -5.38% 12 Week 3.31% -11.76% Year To Date -42.57% -46.21%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10897 SOUTH RIVER FRONT PARKWAY #300 - SOUTH JORDAN,UT 84095 USA ph: 801-708-6800 fax: - ir@healthcatalyst.com http://www.healthcatalyst.com

• General Corporate Information    Officers Daniel Burton - Chief Executive Officer and Director Jason Alger - Chief Financial Officer John A. Kane - Director Duncan Gallagher - Director Jill Hoggard Green - Director Peer Information Health Catalyst, Inc. (HLIS) Health Catalyst, Inc. (AZTA) Health Catalyst, Inc. (APYI) Health Catalyst, Inc. (RNVA) Health Catalyst, Inc. (HMSY) Health Catalyst, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 42225T107 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 69.60 Most Recent Split Date: (:1) Beta: 1.51 Market Capitalization: $282.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.22 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.76 Price/Cash Flow: 11.52 Price / Sales: 0.91 EPS Growth vs. Year Ago Period: 28.57% vs. Previous Quarter: 23.08% Sales Growth vs. Year Ago Period: 6.28% vs. Previous Quarter: -0.24% ROE 06/30/25 - - 03/31/25 - -6.14 12/31/24 - -6.48 ROA 06/30/25 - - 03/31/25 - -2.74 12/31/24 - -3.04 Current Ratio 06/30/25 - - 03/31/25 - 1.24 12/31/24 - 1.43 Quick Ratio 06/30/25 - - 03/31/25 - 1.24 12/31/24 - 1.43 Operating Margin 06/30/25 - - 03/31/25 - -7.17 12/31/24 - -7.58 Net Margin 06/30/25 - - 03/31/25 - -23.34 12/31/24 - -22.67 Pre-Tax Margin 06/30/25 - - 03/31/25 - -23.20 12/31/24 - -22.56 Book Value 06/30/25 - - 03/31/25 - 5.37 12/31/24 - 6.00 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.40 12/31/24 - 0.41 Debt-to-Capital 06/30/25 - - 03/31/25 - 28.65 12/31/24 - 29.28

Powered by Zacks Investment Research ©